LY2228820 dimesylate

LY2228820 dimesylate (Ralimetinib) is a potent, selective, orally available inhibitor p38 MAPK with IC50 of 5.3 and 3.2 nM for p38α and p38β, respectively.

Product Specifications

CAS Number

862507-23-1

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

612.737

Molecular Formula

C26H37FN6O6S2

Notes

Research use only, not for human use.

Receptor

P38α

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

70R-8975 50 ug

PDCD2L antibody

Ask

View Details

SI013085B 1 Each

Human PTEN Pre-designed siRNA Set B

Ask

View Details

FAB9766F 0.1 mL

Mouse Monoclonal CD161 Antibody (10/78) [FITC]

Ask

View Details

MIH03954 2x 5.0 nmol

hsa-miR-942-3p miRNA Inhibitor

Ask

View Details

ELI-06153c 96 Tests

Chicken Tyrosine-protein kinase BTK,BTK ELISA KIT

Ask

View Details

O2971-ML405 100 µL

OASL, CT (59kD 2'-5'-oligoadenylate Synthase-like Protein, p59 OASL, p59OASL, Thyroid Receptor-interacting Protein 14, TR-interacting Protein 14, TRIP-14, TRIP14) (MaxLight 405) discontinued

Ask

View Details